Rosetta Genomics Ltd. (USA) (ROSG) Reaches $0.73 1 Year Low; CH Robinson Worldwide (CHRW) Shorts Down By 5.57%

November 8, 2017 - By Adrian Erickson

CH Robinson Worldwide Incorporated (NASDAQ:CHRW) had a decrease of 5.57% in short interest. CHRW’s SI was 19.15 million shares in November as released by FINRA. Its down 5.57% from 20.28 million shares previously. With 1.64M avg volume, 12 days are for CH Robinson Worldwide Incorporated (NASDAQ:CHRW)’s short sellers to cover CHRW’s short positions. About 446,905 shares traded. C.H. Robinson Worldwide Inc (NASDAQ:CHRW) has declined 7.85% since November 8, 2016 and is downtrending. It has underperformed by 24.55% the S&P500.

The stock of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) hit a new 52-week low and has $0.70 target or 4.00% below today’s $0.73 share price. The 7 months bearish chart indicates high risk for the $2.26M company. The 1-year low was reported on Nov, 8 by Barchart.com. If the $0.70 price target is reached, the company will be worth $90,400 less. About 50,681 shares traded. Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) has declined 87.50% since November 8, 2016 and is downtrending. It has underperformed by 104.20% the S&P500.

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid , micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). The company has market cap of $2.26 million. It is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. It currently has negative earnings. The Company’s therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project.

C.H. Robinson Worldwide, Inc. is a provider of transportation services and logistics solutions through a network of offices operating in North America, Europe, Asia, Australia, New Zealand and South America. The company has market cap of $11.36 billion. The Company’s divisions include North American Surface Transportation , Global Forwarding, Robinson Fresh, and All Other and Corporate. It has a 24.15 P/E ratio. The NAST segment provides freight transportation services across North America through a network of offices in the United States, Canada and Mexico.